Image optimize LCP
  • Add description, images, menus and links to your mega menu

  • A column with no settings can be used as a spacer

  • Link to your collections, sales and even external links

  • Add up to five columns

  • mayo 02, 2023 1 lectura mínima

    Want to know how we help? 

    After years in the field, an international NGO supporting clinics in Tanzania, Uganda, Nigeria, and Haiti, had found that obstetric hemorrhage was one of the biggest preventable causes of maternal mortality. They were then looking to purchase the Non-Pneumatic Anti Shock Garment (NASG), a low-cost, evidence-based, first-aid device used to stabilize women experiencing obstetric hemorrhage. 

    After a thorough search, they found Maternova offered the best path to acquiring the NASG. During discussions with our team, Maternova offered tailored advice on how to best pair the NASG with other low-cost, life-saving devices designed to prevent obstetric hemorrhage, like the CRADLE Vitals Monitor and the Obstetric Ballon. Based on the recommendations made by Maternova’s Chief Medical Officer, Dr. Luna Mehrain, they ordered the three products and incorporated them into their health programs and training sessions. To ease the introduction of the products into the work of their medical teams in Tanzania, Uganda, and Nigeria (50 professionals in total), Dr. Luna Mehrain offered a custom, live training on best practices for the three products.

    This story is one of many where Maternova demonstrated a high level of medical expertise and efficiency to support its NGO clients. Paying close attention to medical innovations in this field, Maternova can offer tailored medical advice and products to your teams, supporting you in promoting maternal and neonatal health around the globe.

    Dejar un comentario

    Los comentarios se aprobarán antes de mostrarse.


    Ver artículo completo

    Planned delivery in late pre-term pre-eclampsia?
    ¿Parto planificado en preeclampsia pretérmino tardía?

    septiembre 30, 2025 2 lectura mínima

    Ver artículo completo
    RAPIDIRON study of intravenous iron UN PHOTO
    Hierro intravenoso en el segundo trimestre: una forma innovadora de abordar la anemia en el embarazo

    septiembre 10, 2025 2 lectura mínima

    " El tratamiento de primera línea de la anemia por deficiencia de hierro materna moderada con infusión de dosis única de hierro intravenoso da como resultado una menor incidencia de recién nacidos con bajo peso ( carboximaltosa férrica intravenosa frente a oral) y una mayor incidencia de alcanzar un estado no anémico materno sin el uso de hierro adicional o transfusión de sangre (carboximaltosa férrica intravenosa y derisomaltosa férrica frente a oral)."

    Ver artículo completo
    Continuous Temperature Monitoring for a Ward full of Newborns
    Monitoreo continuo de temperatura para una sala llena de recién nacidos

    agosto 26, 2025 2 lectura mínima

    Ver artículo completo